MediLiVes (MLIV) ICO review
MediLiVes has brought an opportune moment for a major and much-needed disruption of the current healthcare system. With telemedicine infusion with technology, doctors and patients alike can manage care remotely, increasing efficiency and outcomes.
Medi-Science International Ltd is an official provider and distributor oÿ Medi-Science technoloĀy called Analytical telemedicine system MediLiVes. Medi-Science International Ltd is also the official entity involved in the preparation and execution oÿ the MediLiVes IEO project. It is an innovative company offerinĀ unique, new-Āeneration telemedicine solutions. Telemedicine, based on technoloĀy that enables a patient’s health condition to be monitored ÿrom a distance, is one oÿ the ÿastest-ĀrowinĀ industries in the world.
The versatile nature oÿ our core product means that it can find abnormalities not only in cardioloĀy but also in diabetes, dietetics, civilization diseases, and chronic illnesses.
There are countless examples around the world where comparable achievements have required many years oÿ work. Our effectiveness results mainly ÿrom the conscious use oÿ the latest Microsoÿt technoloĀies such as cloud computinĀ, artificial intelliĀence, and cross-platÿorm soÿtware.
Thanks to numerous visits at scientific and industry conÿerences in The Middle East, London and Europe, Russia, Aÿrica, and Asian countries, United States and many more we have built our position as experts in the telemedicine sector.